|
ES2028074T3
(es)
*
|
1986-06-13 |
1992-07-01 |
Alza Corporation |
Activacion por humedad de un sistema de suministro transdermico de farmacos.
|
|
US5176917A
(en)
*
|
1989-03-15 |
1993-01-05 |
Lts Lohmann |
Transdermal system exhibiting graduated drug release and its use for the local or systemic administration of active substances
|
|
US5104660A
(en)
*
|
1989-11-21 |
1992-04-14 |
Bruce A. Barber |
Method of preparing an antimicrobial wound dressing
|
|
US5227168A
(en)
*
|
1989-11-21 |
1993-07-13 |
Bruce Barber |
Method of treating a wound
|
|
US5116620A
(en)
*
|
1989-11-21 |
1992-05-26 |
Bruce A. Barber |
Antimicrobial wound dressing
|
|
US6132849A
(en)
*
|
1990-10-30 |
2000-10-17 |
Minnesota Mining And Manufacturing Company |
Receptive media for permanent imaging and methods of preparing and using same
|
|
US5443727A
(en)
*
|
1990-10-30 |
1995-08-22 |
Minnesota Mining And Manufacturing Company |
Articles having a polymeric shell and method for preparing same
|
|
CA2076574A1
(en)
*
|
1991-10-01 |
1993-04-02 |
John Lenneis Haynes |
Extended-life drug filled patch
|
|
CA2187023A1
(en)
*
|
1994-04-13 |
1995-10-26 |
Steven Andrew Giannos |
Temporally controlled drug delivery systems
|
|
GB9515807D0
(en)
*
|
1995-08-02 |
1995-10-04 |
Cantwell Evelyna D |
Topical hyperbaric bandage
|
|
US5730721A
(en)
*
|
1996-01-25 |
1998-03-24 |
Vesture Corporation |
Medical applicator and method
|
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
|
US20060002959A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Government Of The United States |
Skin-sctive adjuvants for transcutaneous immuization
|
|
US20060002949A1
(en)
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
US5980898A
(en)
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US6019997A
(en)
*
|
1997-01-09 |
2000-02-01 |
Minnesota Mining And Manufacturing |
Hydroalcoholic compositions for transdermal penetration of pharmaceutical agents
|
|
US7150881B2
(en)
*
|
1997-06-26 |
2006-12-19 |
Mylan Technologies, Inc. |
Adhesive mixture for transdermal delivery of highly plasticizing drugs
|
|
US6660295B2
(en)
|
1997-09-30 |
2003-12-09 |
Alza Corporation |
Transdermal drug delivery device package with improved drug stability
|
|
US20040258703A1
(en)
*
|
1997-11-14 |
2004-12-23 |
The Government Of The Us, As Represented By The Secretary Of The Army |
Skin-active adjuvants for transcutaneous immunization
|
|
US6699497B1
(en)
|
1998-07-24 |
2004-03-02 |
Alza Corporation |
Formulations for the transdermal administration of fenoldopam
|
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
|
US6348210B1
(en)
|
1998-11-13 |
2002-02-19 |
Alza Corporation |
Methods for transdermal drug administration
|
|
HUP0104728A3
(en)
|
1998-12-18 |
2006-07-28 |
Alza Corp Mountain View |
Transparent transdermal nicotine delivery device
|
|
WO2000048541A1
(en)
*
|
1999-02-19 |
2000-08-24 |
Brooks Norman A |
Zinc chloride in treating skin diseases
|
|
US6337328B1
(en)
|
1999-03-01 |
2002-01-08 |
Sepracor, Inc. |
Bupropion metabolites and methods of use
|
|
AU3932600A
(en)
*
|
1999-04-01 |
2000-10-23 |
Alza Corporation |
Transdermal drug delivery devices comprising a polyurethane drug reservoir
|
|
WO2000061184A2
(en)
*
|
1999-04-08 |
2000-10-19 |
Glenn Gregory M |
Dry formulation for transcutaneous immunization
|
|
US6812205B2
(en)
|
2000-03-15 |
2004-11-02 |
The Brigham & Women's Hospital, Inc. |
Suppression of vascular disorders by mucosal administration of heat shock protein peptides
|
|
US20020197235A1
(en)
*
|
2000-11-03 |
2002-12-26 |
Moran Stanford Mark |
Method for short-term and long-term drug dosimetry
|
|
PT1372708E
(pt)
*
|
2001-02-13 |
2008-09-29 |
Us Gov Sec Army |
Vacina para imunização transcutânea
|
|
US7776379B2
(en)
*
|
2001-09-19 |
2010-08-17 |
Medlogics Device Corporation |
Metallic structures incorporating bioactive materials and methods for creating the same
|
|
US20030060873A1
(en)
*
|
2001-09-19 |
2003-03-27 |
Nanomedical Technologies, Inc. |
Metallic structures incorporating bioactive materials and methods for creating the same
|
|
CA2466228A1
(en)
*
|
2001-11-09 |
2003-08-07 |
Biomedicines, Inc. |
Method for treating diseases with omega interferon
|
|
US20060100695A1
(en)
*
|
2002-09-27 |
2006-05-11 |
Peacock James C Iii |
Implantable stent with modified ends
|
|
US7731947B2
(en)
|
2003-11-17 |
2010-06-08 |
Intarcia Therapeutics, Inc. |
Composition and dosage form comprising an interferon particle formulation and suspending vehicle
|
|
US20040258742A1
(en)
*
|
2003-04-11 |
2004-12-23 |
Van Osdol William Woodson |
Transdermal administration of N-(2,5-disubstituted phenyl)-N'-(3-substituted phenyl)-N'-methyl guanidines
|
|
EP1682211B1
(en)
*
|
2003-10-27 |
2009-11-18 |
Universität Basel |
Transdermal drug delivery system
|
|
US20070191815A1
(en)
*
|
2004-09-13 |
2007-08-16 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
US7208172B2
(en)
*
|
2003-11-03 |
2007-04-24 |
Medlogics Device Corporation |
Metallic composite coating for delivery of therapeutic agents from the surface of implantable devices
|
|
US20060085062A1
(en)
*
|
2003-11-28 |
2006-04-20 |
Medlogics Device Corporation |
Implantable stent with endothelialization factor
|
|
US20050119723A1
(en)
*
|
2003-11-28 |
2005-06-02 |
Medlogics Device Corporation |
Medical device with porous surface containing bioerodable bioactive composites and related methods
|
|
US8252321B2
(en)
*
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
EP1835933A4
(en)
|
2005-01-04 |
2015-01-07 |
Yeda Res & Dev |
HSP60, HSP60-PEPTIDES AND T-CELL VACCINES FOR IMMUNOMODULATION
|
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
|
WO2006083761A2
(en)
|
2005-02-03 |
2006-08-10 |
Alza Corporation |
Solvent/polymer solutions as suspension vehicles
|
|
WO2006109312A2
(en)
*
|
2005-04-15 |
2006-10-19 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
|
|
US8372040B2
(en)
|
2005-05-24 |
2013-02-12 |
Chrono Therapeutics, Inc. |
Portable drug delivery device including a detachable and replaceable administration or dosing element
|
|
US8287923B2
(en)
*
|
2005-06-10 |
2012-10-16 |
Medical College Of Georgia Research Institute, Inc. |
Compositions and methods for treating immune disorders
|
|
US9446017B2
(en)
|
2005-08-11 |
2016-09-20 |
Augusta University Research Institute, Inc. |
Compositions and methods for treating herpes simplex virus
|
|
US20070259930A1
(en)
*
|
2006-04-10 |
2007-11-08 |
Knopp Neurosciences, Inc. |
Compositions and methods of using r(+) pramipexole
|
|
US8518926B2
(en)
*
|
2006-04-10 |
2013-08-27 |
Knopp Neurosciences, Inc. |
Compositions and methods of using (R)-pramipexole
|
|
KR20090021169A
(ko)
*
|
2006-05-16 |
2009-02-27 |
크놉 뉴로사이언시스 인코포레이티드 |
Ｒ(+) 및 ｓ(-) 프라미펙솔을 포함하는 조성물 및 이의 사용 방법
|
|
KR101106510B1
(ko)
|
2006-05-30 |
2012-01-20 |
인타르시아 세라퓨틱스 인코포레이티드 |
투피스, 내부채널 삼투압 전달 시스템 유동 조절기
|
|
CA2670821C
(en)
|
2006-08-09 |
2012-05-15 |
Intarcia Therapeutics, Inc. |
Osmotic delivery systems and piston assemblies
|
|
US9114133B2
(en)
|
2006-08-25 |
2015-08-25 |
U.S. Dept. Of Veterans Affairs |
Method of improving diastolic dysfunction
|
|
US8524695B2
(en)
*
|
2006-12-14 |
2013-09-03 |
Knopp Neurosciences, Inc. |
Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
|
|
CN101715443A
(zh)
|
2007-03-14 |
2010-05-26 |
诺普神经科学股份有限公司 |
手性纯化的取代的苯并噻唑二胺的合成
|
|
CA2683610C
(en)
|
2007-04-23 |
2013-01-08 |
Intarcia Therapeutics, Inc. |
Suspension formulations of insulinotropic peptides and uses thereof
|
|
WO2009102467A2
(en)
|
2008-02-13 |
2009-08-20 |
Intarcia Therapeutics, Inc. |
Devices, formulations, and methods for delivery of multiple beneficial agents
|
|
US20110190356A1
(en)
*
|
2008-08-19 |
2011-08-04 |
Knopp Neurosciences Inc. |
Compositions and Methods of Using (R)- Pramipexole
|
|
CN102802418A
(zh)
*
|
2009-06-19 |
2012-11-28 |
诺普神经科学股份有限公司 |
用于治疗肌萎缩性侧索硬化的组合物和方法
|
|
US20130017188A1
(en)
|
2009-07-31 |
2013-01-17 |
The Brigham And Women's Hospital, Inc. |
Modulation of sgk1 expression in th17 cells to modulate th17-mediated immune responses
|
|
MX378797B
(es)
|
2009-09-28 |
2025-03-10 |
Intarcia Therapeutics Inc |
Establecimiento y/o terminacion rapidos de suministro de estado estable sustancial de farmaco.
|
|
CA2794565C
(en)
|
2010-04-08 |
2018-08-21 |
Emory University |
Substituted androst-4-ene diones
|
|
GB201019761D0
(en)
*
|
2010-11-22 |
2011-01-05 |
Chowdhury Dewan F H |
Multilayered transdermal patch
|
|
JP6527305B2
(ja)
|
2011-01-10 |
2019-06-05 |
インヴィオン， インコーポレイテッド |
禁煙のためのβ−アドレナリン作動性インバースアゴニストの使用
|
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
|
US9585930B2
(en)
|
2011-03-20 |
2017-03-07 |
Trustees Of Boston University |
Therapeutic agent for emphysema and COPD
|
|
WO2012151474A2
(en)
|
2011-05-04 |
2012-11-08 |
Trustees Of Boston University |
Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria
|
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
|
US20130017259A1
(en)
|
2011-07-06 |
2013-01-17 |
The Parkinson's Institute |
Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
|
|
EP2543370A1
(en)
|
2011-07-06 |
2013-01-09 |
Georgia Health Sciences University Research Institute, Inc. |
Compositions and Methods for Treating Herpes Simplex Virus
|
|
US9243037B2
(en)
|
2011-11-10 |
2016-01-26 |
Trustees Of Boston College |
Gramicidin a mutants that function as antibiotics with improved solubility and reduced toxicity
|
|
WO2013096816A1
(en)
|
2011-12-22 |
2013-06-27 |
Biogen Idec Ma Inc. |
Improved synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
|
|
US10105487B2
(en)
|
2013-01-24 |
2018-10-23 |
Chrono Therapeutics Inc. |
Optimized bio-synchronous bioactive agent delivery system
|
|
US20150366890A1
(en)
|
2013-02-25 |
2015-12-24 |
Trustees Of Boston University |
Compositions and methods for treating fungal infections
|
|
US9662313B2
(en)
|
2013-02-28 |
2017-05-30 |
Knopp Biosciences Llc |
Compositions and methods for treating amyotrophic lateral sclerosis in responders
|
|
WO2014188329A2
(en)
|
2013-05-20 |
2014-11-27 |
Mylan, Inc. |
Transdermal therapeutic system for extended dosing of pramipexole in treating neurological disorders
|
|
ES3043076T3
(en)
|
2013-07-12 |
2025-11-24 |
Areteia Therapeutics Inc |
Treating elevated levels of eosinophils and/or basophils
|
|
US9468630B2
(en)
|
2013-07-12 |
2016-10-18 |
Knopp Biosciences Llc |
Compositions and methods for treating conditions related to increased eosinophils
|
|
ES2871556T3
(es)
|
2013-08-13 |
2021-10-29 |
Knopp Biosciences Llc |
Composiciones y métodos para el tratamiento de la urticaria crónica
|
|
WO2015023786A1
(en)
|
2013-08-13 |
2015-02-19 |
Knopp Biosciences Llc |
Compositions and methods for treating plasma cell disorders and b-cell prolymphocytic disorders
|
|
EP3036226B1
(en)
|
2013-08-22 |
2020-01-08 |
The General Hospital Corporation |
Inhibitors of human 12/15-lipoxygenase
|
|
US11382883B2
(en)
|
2013-08-29 |
2022-07-12 |
Trustees Of Boston University |
Intermediate metabolism products to potentiate aminoglycoside antibiotics in bacterial infections
|
|
US9937124B2
(en)
|
2014-09-11 |
2018-04-10 |
International Business Machines Corporation |
Microchip substance delivery devices having low-power electromechanical release mechanisms
|
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
|
WO2016123406A1
(en)
|
2015-01-28 |
2016-08-04 |
Chrono Therapeutics Inc. |
Drug delivery methods and systems
|
|
EP3267875A4
(en)
|
2015-03-12 |
2018-12-05 |
Chrono Therapeutics Inc. |
Craving input and support system
|
|
EP3303286B1
(en)
|
2015-06-01 |
2023-10-04 |
Cedars-Sinai Medical Center |
Compounds that bind to rela of nf-kb for use in treating cancer
|
|
CN113598842A
(zh)
|
2015-06-03 |
2021-11-05 |
因塔西亚制药公司 |
植入物放置和移除系统
|
|
KR102123365B1
(ko)
|
2015-07-28 |
2020-06-16 |
바이옴 테라퓨틱스 리미티드 |
항박테리아 치료제 및 예방제
|
|
US10881788B2
(en)
|
2015-10-30 |
2021-01-05 |
International Business Machines Corporation |
Delivery device including reactive material for programmable discrete delivery of a substance
|
|
KR102574993B1
(ko)
|
2016-05-16 |
2023-09-06 |
인타르시아 세라퓨틱스 인코포레이티드 |
글루카곤-수용체 선택적 폴리펩티드 및 이들의 이용 방법
|
|
USD860451S1
(en)
|
2016-06-02 |
2019-09-17 |
Intarcia Therapeutics, Inc. |
Implant removal tool
|
|
USD840030S1
(en)
|
2016-06-02 |
2019-02-05 |
Intarcia Therapeutics, Inc. |
Implant placement guide
|
|
WO2018129058A1
(en)
|
2017-01-03 |
2018-07-12 |
Intarcia Therapeutics, Inc. |
Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug
|
|
WO2018129304A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
CA3101966A1
(en)
|
2018-05-29 |
2019-12-05 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
USD933219S1
(en)
|
2018-07-13 |
2021-10-12 |
Intarcia Therapeutics, Inc. |
Implant removal tool and assembly
|
|
US12397141B2
(en)
|
2018-11-16 |
2025-08-26 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|